Eris Lifesciences Limited - Laporan Laba Rugi (TTM)

Eris Lifesciences Limited
IN ˙ NSEI ˙ INE406M01024
₹ 1,728.25 ↓ -29.05 (-1.65%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Eris Lifesciences Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 11,192 11,625 11,926 12,482 12,763 12,993 13,262 13,746 14,766 15,663 16,618 17,298 17,750 18,406 19,913 22,469 24,853 27,239 28,793 29,352
Change (%) 3.87 2.60 4.66 2.25 1.80 2.07 3.65 7.42 6.08 6.10 4.09 2.61 3.70 8.19 12.83 10.61 9.60 5.70 1.94
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 2,051 2,187 2,419 2,495 2,558 2,608 2,640 2,803 3,196 3,469 3,613 3,457 3,435 3,436 3,964 4,822 5,902 6,782 7,332 7,372
Change (%) 6.64 10.64 3.15 2.50 1.96 1.24 6.15 14.03 8.56 4.14 -4.33 -0.63 0.03 15.36 21.67 22.39 14.91 8.10 0.55
% of Revenue 18.32 18.81 20.29 19.99 20.04 20.07 19.91 20.39 21.64 22.15 21.74 19.98 19.35 18.67 19.90 21.46 23.75 24.90 25.46 25.12
Gross Operating Profit 9,141 9,438 9,507 9,987 10,205 10,385 10,621 10,943 11,570 12,194 13,005 13,841 14,315 14,971 15,950 17,646 18,951 20,457 21,461 21,980
Change (%) 3.25 0.73 5.04 2.19 1.77 2.27 3.03 5.73 5.40 6.65 6.43 3.42 4.58 6.54 10.64 7.39 7.95 4.91 2.42
% of Revenue 81.68 81.19 79.71 80.01 79.96 79.93 80.09 79.61 78.36 77.85 78.26 80.02 80.65 81.33 80.10 78.54 76.25 75.10 74.54 74.88
SG&A 2,717 2,790 2,439 2,377 2,553 2,572 2,622 2,773 3,104 3,362 3,548 3,721 3,841 3,958 4,142 4,323 4,773 5,040 5,261 5,379
Change (%) 2.67 -12.57 -2.54 7.39 0.74 1.94 5.78 11.92 8.32 5.53 4.88 3.23 3.04 4.66 4.36 10.41 5.60 4.38 2.24
% of Revenue 24.28 24.00 20.45 19.04 20.00 19.79 19.77 20.18 21.02 21.47 21.35 21.51 21.64 21.50 20.80 19.24 19.21 18.50 18.27 18.33
R&D
Change (%)
% of Revenue
OpEx 7,805 7,913 8,050 8,423 8,597 8,745 9,017 9,563 10,603 11,476 12,402 12,870 13,140 13,572 14,968 17,094 19,007 21,001 21,766 22,006
Change (%) 1.38 1.74 4.63 2.06 1.72 3.10 6.06 10.88 8.23 8.06 3.78 2.09 3.28 10.29 14.20 11.19 10.49 3.64 1.10
% of Revenue 69.74 68.07 67.50 67.48 67.36 67.31 67.99 69.57 71.81 73.27 74.63 74.40 74.03 73.73 75.17 76.08 76.48 77.10 75.60 74.97
Operating Income 3,386 3,712 3,876 4,059 4,166 4,248 4,245 4,183 4,162 4,187 4,217 4,427 4,610 4,835 4,945 5,374 5,846 6,239 7,027 7,346
Change (%) 9.61 4.43 4.72 2.63 1.97 -0.07 -1.47 -0.49 0.59 0.71 5.00 4.12 4.88 2.27 8.69 8.77 6.72 12.63 4.55
% of Revenue 30.26 31.93 32.50 32.52 32.64 32.69 32.01 30.43 28.19 26.73 25.37 25.60 25.97 26.27 24.83 23.92 23.52 22.90 24.40 25.03
Interest Expense -16 -16 -18 -22 -28 -34 -41 -106 -166 -186 -262 -363 -455 -606 -848 -1,278 -1,710 -2,100 -2,313 -2,196
Change (%) 0.75 11.79 20.75 28.22 22.94 20.87 155.57 56.66 11.81 40.98 38.70 25.42 33.21 39.85 50.72 33.78 22.84 10.12 -5.05
% of Revenue -0.14 -0.14 -0.15 -0.17 -0.22 -0.26 -0.31 -0.77 -1.12 -1.19 -1.57 -2.10 -2.56 -3.29 -4.26 -5.69 -6.88 -7.71 -8.03 -7.48
Net Income 3,165 3,432 3,551 3,728 3,834 3,941 4,061 3,940 3,959 3,970 3,822 3,824 3,856 3,864 3,920 3,803 3,485 3,294 3,518 3,865
Change (%) 8.43 3.49 4.97 2.86 2.77 3.06 -2.98 0.48 0.28 -3.75 0.07 0.82 0.23 1.45 -3.00 -8.37 -5.48 6.83 9.86
% of Revenue 28.28 29.52 29.78 29.86 30.04 30.33 30.62 28.67 26.82 25.35 23.00 22.11 21.72 21.00 19.69 16.93 14.02 12.09 12.22 13.17

Source: Capital IQ

Other Listings
IN:540596
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista